BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 10419035)

  • 1. Nasopharyngeal carcinoma.
    Brennan B
    Orphanet J Rare Dis; 2006 Jun; 1():23. PubMed ID: 16800883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethno-geographic distribution and histopathological classification of nasopharyngeal carcinoma in a single center in Nepal.
    Pandit S; Sapkota S; Adhikari A; Karki P; Yadav D; Shrestha R; Yogal R; Chalise S; Pathak R; Jha AK
    PLoS One; 2024; 19(5):e0304371. PubMed ID: 38820402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma.
    Kase K; Kondo S; Wakisaka N; Dochi H; Mizokami H; Kobayashi E; Kano M; Komori T; Hirai N; Ueno T; Nakanishi Y; Hatano M; Endo K; Moriyama-Kita M; Sugimoto H; Yoshizaki T
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33804064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third Epidemiological Analysis of Nasopharyngeal Carcinoma in the Central Region of Japan from 2006 to 2015.
    Kanno M; Narita N; Fujimoto Y; Wakisaka N; Yoshizaki T; Kodaira T; Makita C; Sato Y; Yamazaki K; Wakaoka T; Shimode Y; Tsuji H; Kito R; Ishinaga H; Hosokawa S; Takakura H; Nishimura K; Matoba T; Fujieda S
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31443218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence Trends and Geographical Distribution of Nasopharyngeal Carcinoma in Iran.
    Safavi-Naini A; Raad N; Ghorbani J; Chaibakhsh S; Ramezani-Daryasar R
    Iran J Cancer Prev; 2015; 8(1):24-8. PubMed ID: 26396710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma.
    Zeng X; Xiang J; Wu M; Xiong W; Tang H; Deng M; Li X; Liao Q; Su B; Luo Z; Zhou Y; Zhou M; Zeng Z; Li X; Shen S; Shuai C; Li G; Fang J; Peng S
    PLoS One; 2012; 7(10):e46367. PubMed ID: 23056289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese.
    Xu YF; Liu WL; Dong JQ; Liu WS; Feng QS; Chen LZ; Zeng YX; Zeng MS; Jia WH
    BMC Med Genet; 2010 Nov; 11():161. PubMed ID: 21067616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types.
    Abdulamir AS; Hafidh RR; Abdulmuhaimen N; Abubakar F; Abbas KA
    BMC Public Health; 2008 Dec; 8():400. PubMed ID: 19055849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma].
    Niedobitek G
    Pathologe; 1998 Sep; 19(5):337-44. PubMed ID: 9816588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological research into nasopharyngeal carcinoma in the Chubu region of Japan.
    Takeshita H; Furukawa M; Fujieda S; Shoujaku H; Ookura T; Sakaguchi M; Ito H; Mineta H; Harada T; Matsuura H; Saito H
    Auris Nasus Larynx; 1999 Jul; 26(3):277-86. PubMed ID: 10419035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological analysis of nasopharyngeal carcinoma in the central region of Japan during the period from 1996 to 2005.
    Kimura Y; Suzuki D; Tokunaga T; Takabayashi T; Yamada T; Wakisaka N; Yoshizaki T; Murata H; Miwa K; Shoujaku H; Watanabe Y; Yamada N; Ito Y; Yuta A; Takeuchi K; Hosokawa S; Mineta H; Hasegawa Y; Fujimoto Y; Nakashima T; Fujieda S
    Auris Nasus Larynx; 2011 Apr; 38(2):244-9. PubMed ID: 20817430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus seroepidemiology in China.
    Zeng Y; Pi GH; Deng H; Zhang JM; Wang PC; Wolf H; De Thé G
    AIDS Res; 1986 Dec; 2 Suppl 1():S7-15. PubMed ID: 3030349
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.